Potassium-cit
These highlights do not include all the information needed to use POTASSIUM CITRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CITRATE EXTENDED-RELEASE TABLETS. POTASSIUM CITRATE extended- release tablets, for oral use Initial U.S. Approval: 1985
Approved
Approval ID
5ccd4d38-0dcd-4bf7-96fd-a263ff468e1a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 27, 2021
Manufacturers
FDA
Eywa Pharma Inc
DUNS: 080465609
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Potassium-cit
PRODUCT DETAILS
NDC Product Code71930-050
Application NumberANDA214426
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 7, 2022
Generic NamePotassium-cit
INGREDIENTS (3)
POTASSIUM CITRATEActive
Quantity: 15 meq in 1 1
Code: EE90ONI6FF
Classification: ACTIB
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
potassium-cit
PRODUCT DETAILS
NDC Product Code71930-049
Application NumberANDA214426
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 7, 2022
Generic Namepotassium-cit
INGREDIENTS (3)
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
POTASSIUM CITRATEActive
Quantity: 10 meq in 1 1
Code: EE90ONI6FF
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
Potassium-cit
PRODUCT DETAILS
NDC Product Code71930-048
Application NumberANDA214426
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 7, 2022
Generic NamePotassium-cit
INGREDIENTS (3)
POTASSIUM CITRATEActive
Quantity: 5 meq in 1 1
Code: EE90ONI6FF
Classification: ACTIB
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT